Eléments de l'association

	Yves Agid	49
	Neurologic Examination (drug effects)	18
	Yves Agid *Sauf* Neurologic Examination (drug effects)"	46
	Neurologic Examination (drug effects) *Sauf* Yves Agid"	15
	Yves Agid Et Neurologic Examination (drug effects)	3
	Yves Agid Ou Neurologic Examination (drug effects)	64
	*Corpus*	679

List of bibliographic references

Number of relevant bibliographic references: 3.

Ident.	Authors (with country if any)	Title
000510	Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]	Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
000608	Gouider‐Khouja [France] ; Marie Vidailhet [France] ; Anne-Marie Bonnet [France] ; Jacques Pichon [France] ; Yves Agid [France]	“Pure” striatonigral degeneration and Parkinson's disease: A comparative clinical study
000654	Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse]	Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024